Will You Still Love Me When the Bill Arrives?

Will You Still Love Me When the Bill Arrives?

In the past months, the Food and Drug Administration (FDA) has approved for market a steady stream of acknowledged breakthrough medicines for hepatitis C, LDL cholesterol and cancer immuno-therapy. The Agency has affirmed that it is approving drugs at a consistent pace. But what makes a new medicine “innovative?”

 

 
  Gil Bashe, one of the healthcare industry’s top PR professionals, joins Finn Partners

Gil Bashe, one of the healthcare industry’s top PR professionals, joins Finn Partners

I am pleased to share that on June 15th, Gil Bashe will join our firm as Managing Partner, Finn Partners Health.